These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 19817669)

  • 1. Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.
    Diego L; Atayee R; Helmons P; von Gunten CF
    Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):473-85. PubMed ID: 19817669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylnaltrexone for opioid-induced constipation in advanced illness.
    Thomas J; Karver S; Cooney GA; Chamberlain BH; Watt CK; Slatkin NE; Stambler N; Kremer AB; Israel RJ
    N Engl J Med; 2008 May; 358(22):2332-43. PubMed ID: 18509120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylnaltrexone: MNTX.
    Drugs R D; 2006; 7(6):374-8. PubMed ID: 17073520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
    Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
    J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relistor approved for opioid-related constipation.
    Traynor K
    Am J Health Syst Pharm; 2008 Jun; 65(11):996. PubMed ID: 18499867
    [No Abstract]   [Full Text] [Related]  

  • 6. Methylnaltrexone for opioid-induced constipation in patients with advanced illness: a 3-month open-label treatment extension study.
    Lipman AG; Karver S; Cooney GA; Stambler N; Israel RJ
    J Pain Palliat Care Pharmacother; 2011; 25(2):136-45. PubMed ID: 21657861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylnaltrexone: new drug. Opiate-induced constipation: barely more effective than placebo.
    Prescrire Int; 2009 Aug; 18(102):158. PubMed ID: 19743572
    [No Abstract]   [Full Text] [Related]  

  • 8. Methylnaltrexone bromide: research update of pharmacokinetics following parenteral administration.
    Rotshteyn Y; Boyd TA; Yuan CS
    Expert Opin Drug Metab Toxicol; 2011 Feb; 7(2):227-35. PubMed ID: 21222554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylnaltrexone: a subcutaneous treatment for opioid-induced constipation in palliative care patients.
    Kyle G
    Int J Palliat Nurs; 2009 Nov; 15(11):533-40. PubMed ID: 20081727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subcutaneous methylnaltrexone for the treatment of opioid-induced constipation in patients with advanced illness: a double-blind, randomized, parallel group, dose-ranging study.
    Portenoy RK; Thomas J; Moehl Boatwright ML; Tran D; Galasso FL; Stambler N; Von Gunten CF; Israel RJ
    J Pain Symptom Manage; 2008 May; 35(5):458-68. PubMed ID: 18440447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylnaltrexone for opioid-induced constipation in advanced illness.
    Chappell D; Rehm M; Conzen P
    N Engl J Med; 2008 Sep; 359(10):1071; author reply 1071. PubMed ID: 18777614
    [No Abstract]   [Full Text] [Related]  

  • 12. Methylnaltrexone: treatment for opioid-induced constipation.
    Licup N; Baumrucker SJ
    Am J Hosp Palliat Care; 2011 Feb; 28(1):59-61. PubMed ID: 20801917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacologic treatment of opioid-induced constipation.
    Wang CZ; Yuan CS
    Expert Opin Investig Drugs; 2013 Oct; 22(10):1225-7. PubMed ID: 23834367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.
    Leppert W
    Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylnaltrexone (Relistor) for opioid induced constipation.
    Med Lett Drugs Ther; 2008 Aug; 50(1292):63-4. PubMed ID: 18688204
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-analgesic effects of opioids: management of opioid-induced constipation by peripheral opioid receptor antagonists: prevention or withdrawal?
    Holzer P
    Curr Pharm Des; 2012; 18(37):6010-20. PubMed ID: 22747544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.
    Gatti A; Sabato AF
    Clin Drug Investig; 2012 May; 32(5):293-301. PubMed ID: 22413747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methylnaltrexone for the Treatment of Constipation in Critically Ill Children.
    López J; Fernández SN; Santiago MJ; Urbano J; González R; Fernández-Llamazares C; López-Herce J
    J Clin Gastroenterol; 2016 Apr; 50(4):351-2. PubMed ID: 26950234
    [No Abstract]   [Full Text] [Related]  

  • 19. Methylnaltrexone for treatment of opioid-induced constipation in advanced illness patients.
    Slatkin N; Thomas J; Lipman AG; Wilson G; Boatwright ML; Wellman C; Zhukovsky DS; Stephenson R; Portenoy R; Stambler N; Israel R
    J Support Oncol; 2009; 7(1):39-46. PubMed ID: 19278178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylnaltrexone for opioid-induced constipation in advanced illness.
    Sanz Rubiales A; del Valle Rivero ML
    N Engl J Med; 2008 Sep; 359(10):1070-1; author reply 1071. PubMed ID: 18768955
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.